Back in 2008, the FDA announced that it would require the manufacturers of antiepileptic drugs to add a warning about the increased risk of suicidal thoughts and behaviors to the product’s label. One of the affected manufacturers was GlaxoSmithKline, the organization responsible for the production of the antiepileptic drug, Lamictal. Since 2008, there have been numerous other warnings issued about Lamictal and its dangerous side effects, including Stevens-Johnson Syndrome, aseptic meningitis, Toxic Epidermal Necrolysis (TEN), and serious birth defects.
With the FDA bringing to light the possibility of suicidal thoughts and behaviors amongst individuals prescribed Lamictal, other questions arose concerning this dangerous drug. First and foremost, experts acknowledge the importance of monitoring patients taking antiepileptic drugs, such as Lamictal. This is done in order to catch any signs of worsening depression, suicidal thoughts or behavior, and any unusual changes in mood or behavior overall. In many cases, those prescribed Lamictal were children or young adults, which gave even more cause for concern.
Here at Wormington & Bollinger, our team of Lamictal lawyers have represented numerous people throughout Texas on cases brought against the manufacturer of Lamictal. If you or someone you love has experienced any negative side effects, such as suicidal thoughts and increased depression, after taking Lamictal, please contact us today.
As mentioned, some antiepileptic drugs, such as Lamictal, are now known to be associated with a higher risk of suicide and violent death. While experts caution that patients should not stop taking Lamictal without their doctor’s permission, this is something that we need to be aware of. Unfortunately, it is still not clear exactly why Lamictal and other antiepileptic drugs – Neurontin, Trileptal, Gabitril, and Depakote – increase the risks of dangerous, negative thoughts in patients. While it is true that the vast majority of patients do not experience any of these thoughts, there have still been a handful of known cases where the person taking Lamictal or one of the other drugs mentioned exhibited suicidal behavior. According to a study conducted by the FDA in 2008, the risk that patients taking on of the 11 listed anticonvulsants were suicidal was about 1 in 230, according to about 1 in 450 in people taking a placebo.
Because of this, the FDA decided to issue a warning about this increased risk. The use of anticonvulsants has risk in recent years, among adults as well as children and teens. In many cases, doctors have turned to prescribing off-label drugs, which means they are not approved by the FDA. In the case of Lamictal, more and more people have begun to step forward with stories of experiencing serious side effects, including thoughts of suicide.
If you have taken Lamictal and have had suicidal thoughts or have become increasingly anxious or depressed, please contact Wormington & Bollinger today. We are dedicated to helping residents throughout Texas bring their case to court and hold GlaxoSmithKline responsible for the dangers associated with their drug, Lamictal.